Market Overview

Saranas Announces Scheduled Presentations at TVT 2018 in Chicago

Share:

Saranas Inc., a medical device company with innovative technology for
real-time detection and monitoring of internal bleeding during
endovascular procedures, has been invited to present at the
Transcatheter Valve Therapies (TVT) Structural Heart Disease Summit,
which will take place June 20-23 at the Sheraton Grand Chicago.
Scheduled presentations of interest include a moderated poster session
by Philippe Généreux, MD, Saranas Chief Medical Officer and Co-Director
of the Structural Heart Disease Program at Morristown Medical Center,
Morristown, New Jersey, on Thursday, June 21 at 11:30 AM. Dr. Généreux
will present results from the FDA-mandated validation study designed to
assess the performance and safety of the Early Bird™ Bleed Monitoring
System.

"Data from this robust animal study demonstrates the Early Bird's
efficacy in positively detecting the onset and progression of internal
bleeds. As designed, the Early Bird System may protect, and in some
cases, save the lives of patients undergoing an endovascular procedure
by allowing physicians to detect the onset of bleeding early and to take
appropriate steps to address the bleed before detrimental, irreversible,
and life-threatening consequences occur," stated Dr. Généreux.

An innovation presentation as part of the TVT Main Arena Day II on
Friday, June 22 at 2 PM, will review the science of bioimpedance
monitoring and the potential application of the Early Bird Bleed
Monitoring System during endovascular procedures. Also, on Friday, June
22 at 12 PM, Saranas, Inc. is supporting the Lunch Satellite Program:
Optimization of Vessel Access and Closure in Large Bore Catheter
Procedure Tips and Tricks Case-Based Review.

President and CEO Zaffer Syed said, "We are excited to showcase the
Early Bird System and to report the latest study data at TVT. We believe
the Early Bird System may significantly reduce bleeding complications
and improve clinical outcomes in patients
undergoing endovascular procedures."

The Early Bird Bleed Monitoring System includes a vascular access sheath
with embedded sensors that are designed to detect and monitor bleeding
from a blood vessel accidentally injured during endovascular procedures,
such as a transcatheter aortic valve replacement (TAVR), large bore
hemodynamic support device placement, or other complex cardiovascular
interventions, where the femoral artery or vein is used to obtain
vascular access. The technology was invented at the Texas Heart
Institute.

About Saranas

Saranas is a privately held Houston-based medical device company focused
on improving patient outcomes through early detection and monitoring of
internal bleeding complications. The company's patented bleed monitoring
system for vascular access procedures enables physicians to mitigate
downstream consequences by addressing bleeding complications
immediately, improving patient outcomes and lowering healthcare costs.
For more information, visit www.saranas.com.

View Comments and Join the Discussion!